Cargando…

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis

OBJECTIVE: The number, unpredictability, and severity of seizures experienced by patients with Dravet syndrome (DS) negatively impact quality of life (QOL) for patients, caregivers, and families. Metrics are needed to assess whether patients with residual seizures have moved meaningfully toward seiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Joseph, Specchio, Nicola, Devinsky, Orrin, Auvin, Stéphane, Perry, M. Scott, Strzelczyk, Adam, Gil‐Nagel, Antonio, Dai, David, Galer, Bradley S., Gammaitoni, Arnold R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297857/ https://www.ncbi.nlm.nih.gov/pubmed/34676542 http://dx.doi.org/10.1111/epi.17106

Ejemplares similares

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
por: Schoonjans, A., et al.
Publicado: (2016)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study
por: Sullivan, Joseph, et al.
Publicado: (2020)

Novel seizure outcomes in patients with Lennox‐Gastaut syndrome: Post hoc analysis of seizure‐free days in rufinamide Study 303
por: Auvin, Stéphane, et al.
Publicado: (2019)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
por: Knupp, Kelly G., et al.
Publicado: (2022)

A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Seizure Clusters: Morbidity and Mortality
por: Bauman, Kristie, et al.
Publicado: (2021)

Seize the Day for a Day With No Seizures: Modifiable Midlife Risk Factors Identified
por: Koubeissi, Mohamad
Publicado: (2019)

Multi-day rhythms modulate seizure risk in epilepsy
por: Baud, Maxime O., et al.
Publicado: (2018)

SUDEP in patients with epilepsy and nonepileptic seizures
por: Verducci, Chloe, et al.
Publicado: (2019)

Role of seizure in neonatal stroke
por: Auvin, Stéphane, et al.
Publicado: (2017)

Circannual seizure provocation as the day lengthens in the northern and southern hemispheres
por: Ng, Marcus C., et al.
Publicado: (2023)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration Studies
por: Pinsent, Amy, et al.
Publicado: (2023)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
por: Meador, Kimford J.
Publicado: (2014)

Seizure‐related deaths in children: The expanding spectrum
por: Harowitz, Jenna, et al.
Publicado: (2021)

Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007)

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series
por: Aledo‐Serrano, Ángel, et al.
Publicado: (2022)

Seizure control in a patient with Dravet syndrome and cystic fibrosis()
por: Schmalbach, Barbara, et al.
Publicado: (2013)

A review of fenfluramine for the treatment of Dravet syndrome patients
por: Simon, Kayla, et al.
Publicado: (2021)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
por: Lai, Wyman W., et al.
Publicado: (2020)

Increased Seizure Susceptibility in Mice 30 Days after Fluid Percussion Injury
por: Mukherjee, Sanjib, et al.
Publicado: (2013)

Seizure likelihood varies with day-to-day variations in sleep duration in patients with refractory focal epilepsy: A longitudinal electroencephalography investigation
por: Dell, Katrina L., et al.
Publicado: (2021)

Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
por: Ho, Shih-Yin, et al.
Publicado: (2021)

Seizure Clusters, Seizure Severity Markers, and SUDEP Risk
por: Ochoa-Urrea, Manuela, et al.
Publicado: (2021)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Accuracy of seizure semiology obtained from first-time seizure witnesses
por: Muayqil, Taim A., et al.
Publicado: (2018)

Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
por: Griffin, Aliesha, et al.
Publicado: (2018)

Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome
por: Wong, Jennifer C., et al.
Publicado: (2019)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
por: Ritter-Makinson, Stefanie, et al.
Publicado: (2019)

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a(+/)(-) mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2023)

Continuous monitoring devices and seizure patterns by glucose, time and lateralized seizure onset()
por: Kinnear, Katie M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6o0pfnrmqnen7ubjpflrgc30nt